Deep Genomics is at the forefront of using artificial intelligence to transform drug discovery. Our proprietary AI platform decodes the complexity of RNA biology to identify novel drug targets, mechanisms, and therapeutics inaccessible through traditional methods. With expertise spanning machine learning, bioinformatics, data science, engineering, and drug development, our multidisciplinary team in Toronto and Cambridge, MA is revolutionizing how new medicines are created.

 

This role based in Cambridge, MA is focused on the analytical characterization and formulation of oligonucleotides in support of the research efforts at Deep Genomics.  The individual in this role will assure the identity and purity levels of oligonucleotides as they are obtained from external CROs as well as from pre-clinical in vitro and in vivo metabolism experiments.  The person in this role will also be responsible for the formulation of oligonucleotides for in vitro and in vivo experimentation.  Further, responsibility for the management of research samples falls within the remit of this role.  The person in this role will also lead the strategy formulation and implementation of an internal build of oligonucleotide analytics lab at Deep Genomics.